Put It on the Board, 3/15

Create PDF

AMP outlines laboratory view on incidental findings

FDA sheds light on digital pathology standards

New guidelines for determining disease-causing potential of genetic variants

[hr]

AMP outlines laboratory view on incidental findings

The American College of Medical Genetics and Genomics’ controversial 2013 recommendations on the reporting of incidental findings on select genes was the first attempt to address the matter in the clinical setting. But the ACMG’s recommendations pose significant challenges that labs undertaking next-generation sequencing must be prepared to address, said a special report written by an Association for Molecular Pathology working group.